Literature DB >> 22374730

C-reactive protein levels are associated with the progression of atherosclerotic lesions in rabbits.

Q Yu1, Y Li, Y Wang, S Zhao, P Yang, Y Chen, J Fan, E Liu.   

Abstract

Elevated plasma levels of C-reactive protein (CRP) are associated with increased risk of cardiovascular disease. CRP immunoreactive protein is also detected in the lesions of atherosclerosis. However, it is not known whether the CRP contents of atherosclerotic lesions are associated with the initiation and progression of atherosclerosis. To examine this hypothesis, we investigated different types of atherosclerotic lesions of rabbits fed with a cholesterol-rich diet for 6, 12, 16, and 28 weeks and examined their relationship with CRP. We measured the aortic atherosclerotic area, macrophages, and smooth muscle cells along with CRP contents in the lesions. Atherosclerotic lesions of aortas began to form at 6 weeks and were characterized by accumulation of macrophages in the intima, and lesions became more fibrotic in the advanced stage. Both plasma CRP levels and the lesional CRP contents were associated with the lesion size. Our results suggest that plasma CRP, as well as lesional CRP, associated with the formation and progression of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374730     DOI: 10.14670/HH-27.529

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  8 in total

1.  Elevations in C-reactive protein and endothelin-1 system activity in humans.

Authors:  Caitlin A Dow; Danielle L Templeton; Grace M Lincenberg; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Life Sci       Date:  2015-12-11       Impact factor: 5.037

Review 2.  C-reactive protein in human atherogenesis: facts and fiction.

Authors:  Oliver Zimmermann; Kefei Li; Myron Zaczkiewicz; Matthias Graf; Zhongmin Liu; Jan Torzewski
Journal:  Mediators Inflamm       Date:  2014-04-01       Impact factor: 4.711

Review 3.  Evolution of C-Reactive Protein.

Authors:  Asmita Pathak; Alok Agrawal
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

4.  Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.

Authors:  Yanli Wang; Liang Bai; Yan Lin; Yulong Chen; Hua Guan; Ninghong Zhu; Yafeng Li; Shoucui Gao; Lijing Sun; Sihai Zhao; Jianglin Fan; Enqi Liu
Journal:  Lipids Health Dis       Date:  2015-07-29       Impact factor: 3.876

5.  Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.

Authors:  Yuka Keyamura; Chifumi Nagano; Masayuki Kohashi; Manabu Niimi; Masanori Nozako; Takashi Koyama; Reiko Yasufuku; Ayako Imaizumi; Hiroyuki Itabe; Tomohiro Yoshikawa
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

Review 6.  Recognition functions of pentameric C-reactive protein in cardiovascular disease.

Authors:  Alok Agrawal; Toh B Gang; Antonio E Rusiñol
Journal:  Mediators Inflamm       Date:  2014-05-19       Impact factor: 4.711

7.  Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response.

Authors:  Weirong Wang; Yulong Chen; Liang Bai; Sihai Zhao; Rong Wang; Baoning Liu; Yali Zhang; Jianglin Fan; Enqi Liu
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

Review 8.  Functionality of C-Reactive Protein for Atheroprotection.

Authors:  Sanjay K Singh; Alok Agrawal
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.